Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma.
Sørbye
H
H
Department of Oncology, Haukeland University Hospital, Bergen, Norway. half@helse-bergen.no
Westre
B
B
Horn
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D018278:Carcinoma, Neuroendocrine / Q000000981:diagnostic imaging / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D010179:Pancreas / Q000000981:diagnostic imaging; D012074:Remission Induction; D014057:Tomography, X-Ray Computed
D005047:Etoposide; D002945:Cisplatin